Cargando…
Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey
OBJECTIVES: To identify sex and age differences in clinically significant symptoms of depression and anxiety and the factors associated with these differences among adults in Australia during COVID-19-related restrictions. DESIGN: Anonymous online survey. SETTING: Australia. PARTICIPANTS: Adults age...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688441/ https://www.ncbi.nlm.nih.gov/pubmed/33234659 http://dx.doi.org/10.1136/bmjopen-2020-042696 |
_version_ | 1783613709439991808 |
---|---|
author | Hammarberg, Karin Tran, Thach Kirkman, Maggie Fisher, Jane |
author_facet | Hammarberg, Karin Tran, Thach Kirkman, Maggie Fisher, Jane |
author_sort | Hammarberg, Karin |
collection | PubMed |
description | OBJECTIVES: To identify sex and age differences in clinically significant symptoms of depression and anxiety and the factors associated with these differences among adults in Australia during COVID-19-related restrictions. DESIGN: Anonymous online survey. SETTING: Australia. PARTICIPANTS: Adults aged over 18 years living in Australia were eligible and 13 829 contributed complete data. Of these, 13 762 identified as female (10 434) or male (3328) and were included in analyses. INTERVENTIONS: None. OUTCOME MEASURES: Clinically significant symptoms of depression (≥10 on Patient Health Questionnaire 9) or anxiety (≥10 on Generalized Anxiety Disorder Scale 7 (GAD-7)), and experiences of irritability (GAD-7 item 6). RESULTS: Women were more likely than men to have clinically significant symptoms of depression (26.3% (95% CI 25.4 to 27.1) vs 20.1% (95% CI 18.7 to 21.5), p<0.001) and anxiety (21.8% (95% CI 21.0 to 22.6) vs 14.2% (95% CI 13.0 to 15.4), p<0.001) and to have experienced irritability in the previous fortnight (63.1% (95% CI 62.1 to 64.0) vs 51.4% (95% CI 49.7 to 53.2), p<0.001). They were also more likely than men to be doing unpaid work caring for children (22.8% (95% CI 22.0 to 23.6) vs 8.6% (95% CI 7.7 to 9.6), p<0.001) and dependent relatives (9.8% (95% CI 9.2 to 10.3) vs 5.7% (95% CI 4.9 to 6.5), p<0.001) which made significant contributions to the mental health outcomes of interest. Loss of employment, fear of contracting COVID-19 and feeling a severe impact of the restrictions were associated with poorer mental health in women and men of all ages. CONCLUSIONS: Rates of clinically significant symptoms of depression and anxiety were higher among women than men. Rather than being intrinsically more vulnerable to mental health problems during the COVID-19 pandemic, the higher risk of symptoms of anxiety and depression among women may in part be explained by their disproportionate burden of unpaid caregiving. |
format | Online Article Text |
id | pubmed-7688441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-76884412020-11-30 Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey Hammarberg, Karin Tran, Thach Kirkman, Maggie Fisher, Jane BMJ Open Mental Health OBJECTIVES: To identify sex and age differences in clinically significant symptoms of depression and anxiety and the factors associated with these differences among adults in Australia during COVID-19-related restrictions. DESIGN: Anonymous online survey. SETTING: Australia. PARTICIPANTS: Adults aged over 18 years living in Australia were eligible and 13 829 contributed complete data. Of these, 13 762 identified as female (10 434) or male (3328) and were included in analyses. INTERVENTIONS: None. OUTCOME MEASURES: Clinically significant symptoms of depression (≥10 on Patient Health Questionnaire 9) or anxiety (≥10 on Generalized Anxiety Disorder Scale 7 (GAD-7)), and experiences of irritability (GAD-7 item 6). RESULTS: Women were more likely than men to have clinically significant symptoms of depression (26.3% (95% CI 25.4 to 27.1) vs 20.1% (95% CI 18.7 to 21.5), p<0.001) and anxiety (21.8% (95% CI 21.0 to 22.6) vs 14.2% (95% CI 13.0 to 15.4), p<0.001) and to have experienced irritability in the previous fortnight (63.1% (95% CI 62.1 to 64.0) vs 51.4% (95% CI 49.7 to 53.2), p<0.001). They were also more likely than men to be doing unpaid work caring for children (22.8% (95% CI 22.0 to 23.6) vs 8.6% (95% CI 7.7 to 9.6), p<0.001) and dependent relatives (9.8% (95% CI 9.2 to 10.3) vs 5.7% (95% CI 4.9 to 6.5), p<0.001) which made significant contributions to the mental health outcomes of interest. Loss of employment, fear of contracting COVID-19 and feeling a severe impact of the restrictions were associated with poorer mental health in women and men of all ages. CONCLUSIONS: Rates of clinically significant symptoms of depression and anxiety were higher among women than men. Rather than being intrinsically more vulnerable to mental health problems during the COVID-19 pandemic, the higher risk of symptoms of anxiety and depression among women may in part be explained by their disproportionate burden of unpaid caregiving. BMJ Publishing Group 2020-11-24 /pmc/articles/PMC7688441/ /pubmed/33234659 http://dx.doi.org/10.1136/bmjopen-2020-042696 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Mental Health Hammarberg, Karin Tran, Thach Kirkman, Maggie Fisher, Jane Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title | Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title_full | Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title_fullStr | Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title_full_unstemmed | Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title_short | Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey |
title_sort | sex and age differences in clinically significant symptoms of depression and anxiety among people in australia in the first month of covid-19 restrictions: a national survey |
topic | Mental Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688441/ https://www.ncbi.nlm.nih.gov/pubmed/33234659 http://dx.doi.org/10.1136/bmjopen-2020-042696 |
work_keys_str_mv | AT hammarbergkarin sexandagedifferencesinclinicallysignificantsymptomsofdepressionandanxietyamongpeopleinaustraliainthefirstmonthofcovid19restrictionsanationalsurvey AT tranthach sexandagedifferencesinclinicallysignificantsymptomsofdepressionandanxietyamongpeopleinaustraliainthefirstmonthofcovid19restrictionsanationalsurvey AT kirkmanmaggie sexandagedifferencesinclinicallysignificantsymptomsofdepressionandanxietyamongpeopleinaustraliainthefirstmonthofcovid19restrictionsanationalsurvey AT fisherjane sexandagedifferencesinclinicallysignificantsymptomsofdepressionandanxietyamongpeopleinaustraliainthefirstmonthofcovid19restrictionsanationalsurvey |